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Focal nodular hyperplasia (FNH) is an uncommon benign mass
lesion of the liver. Pathologically, FNH does not contain a
portal venous system within the nodule, and so an arterioportal
(AP) shunt is unlikely to coexist with FNH. Such a case has not
been reported to our knowledge, though many FNH images
have been published so far. We present such a case in this
report and discuss the relationship between the FNH nodule and
AP shunt.
CASE REPORT
A previously healthy 40 year old woman presented complaining of
abdominal “uneasiness”. Laboratory data were unremarkable. On abdomi-
nal ultrasound (US), the entire liver showed increased echogenicity,
indicating fatty infiltration of the liver. A slightly hypoechoic lesion of
about 1 cm in diameter was found incidentally in the posterior segment of
the liver (Fig. 1). To investigate further two-phase dynamic computed
tomography (CT) was performed the next day, and the arterial phase image
showed not only a hypervascular mass, but also a transient segmental
hyperattenuation (TSH) area with a straight border adjacent to the mass,
which indicated coexistent AP shunt (Fig. 2a). Both the mass and TSH area
became iso-dense to the surrounding liver parenchyma in the late phase
(not shown). They appeared as a defect on CT arterial portography (CTAP)
(Fig. 2b). On magnetic resonance imaging (MRI), the mass was iso-intense
with the surrounding liver parenchyma on T1-weighted image, and hyper-
intense on T2-weighted image (not shown). The patient was negative for
serum alpha-feto protein, protein-induced by vitamin K absence-2, hepatits
B and C virus, and had no history of oral contraceptive use. Although FNH
was strongly suspected, the AP shunt made the diagnosis uncertain;
hepatocellular carcinoma (HCC) may have been a possible diagnosis. The
patient wanted surgical resection of the lesion, and a partial hepatectomy
was performed. The pathological diagnosis was FNH (Fig. 3), and focal
spared area in the fatty liver around the FNH nodule was also noted. The
sinusoidal system of this area was moderately dilated, indicating an
irregular vascular supply within the area.
DISCUSSION
FNH is a tumour-mimicking mass lesion of the liver, which
primarily occurs in young women. The aetiology of FNH is still
uncertain, but most recent papers favour the hypothesis that
FNH lesions are a hyperplastic response of normal hepatocytes
to an irregular vascular supply [1]. As FNH rarely poses a
clinical problem, it rarely requires invasive treatment such as
surgical resection or transarterial embolization [2].
The diagnosis of FNH is usually not so difficult, as imaging
findings of FNH have been well documented: on dynamic
CT, lesions are homogeneous and slightly hypo- or isoattenuat-
ing on precontrast scan, hyperattenuating on arterial phase scan,
isoattenuating on delayed scan. A central scar may appear
hyperattenuating on delayed CT [2,3]. On MRI, iso- or
hypointensity on T1-weighted images and lesions show slight
hyper- or isointensity on T2-weighted images. The central scar
appears hyperintense on T2-weighted images [3]. On angio-
graphy, wheel-spoke shaped tumour vessels are typical of FNH
[1]. US is also able to depict tumour vessels using an echo-
enhancing agent [4]. The images of the present case were
similar to these findings, therefore FNH was the most likely
diagnosis. The AP shunt, however, made the diagnosis
questionable, because an AP shunt accompanying FNH has
not been previously reported in the available literature.
AP shunt is a vascular abnormality of the liver, which occurs
in various conditions such as HCC, haemangioma, previous
liver biopsy, portal vein obstruction, and hepatic vein
obstruction [5,6]. Among these, HCC is the most frequent
malignant cause [5], and so HCC should be considered when
there is AP shunt within or around a mass lesion in the liver. An
AP shunt causes TSH within the affected area of the liver on
multi-phase dynamic CT [6]. When TSH is depicted, as in our
case, it strongly suggests the existence of an AP shunt. AP
shunts sometimes cause focal fat-spared areas in the fatty liver
[7]; this was also found in the present case (Fig. 3).
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Pathologically, FNH includes all components of hepatic
lobules, but lacks a portal venous system in the nodule [8].
Accordingly, an AP shunt is not likely to occur within FNH
nodules.
There are two possibilities regarding the relationship
between the FNH nodule and the coexistent AP shunt in the
present case. First, the AP shunt may have preceded the FNH.
The AP shunt provided an irregular vascular supply to the
affected area, and the irregular vascular supply could have
caused FNH. Second, conversely, the FNH may have preceded
Fig. 1 – Ultrasonography, right intercostal scan. There was a slightly
hypoechoic lesion (white arrows) in the liver. Arrowheads: surface of the
liver.
Fig. 2 – (a ) Arterial phase dynamic CT taken 30 s after the injection of
contrast medium. A hypervascular mass (arrow) and transient segmental
hyperattenuation area (arrowheads) were shown. RK: right kidney. (b )
CTAP. Both the mass and TSH area were depicted as unenhanced areas
(arrow). The shape of the TSH area was a little different from a, likely due
to the difference of the slice level.
Fig. 3 – (a ) The resected specimen. There was a diffuse fatty infiltration of
the liver parenchyma (asterisks). The whitish mass was the FNH. Around
the FNH, there was fat-spared area (arrowheads). On careful comparison of
the specimen with the images, the shape and size of this area corresponded
to the TSH area shown in the CT and CTAP images. The sinusoidal system
in this area was dilated, likely due to increased blood flow caused by the AP
shunt. (a ) The resected specimen, Sudan3 fat-stained. Diffuse fatty
infiltration of the liver (asterisks) and focal steatosis in the FNH nodule
(arrowheads) were depicted. The spared area in fatty liver (arrows)
corresponded to the TSH area on CT (Fig. 2).
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and caused the AP shunt. Any hepatic nodule, including FNH,
can compress and occlude an adjacent hepatic vein or portal
vein, and the occlusion of these vein(s) may cause an AP shunt.
As FNH is a hypervascular mass, steal phenomenon was
another possible cause of the AP shunt [5]. Thus, FNH can
cause an AP shunt.
In conclusion, FNH can accompany an AP shunt, therefore
the presence of an AP shunt cannot exclude the diagnosis of
FNH.
Acknowledgements. The authors thank Dr Suzuko Moritani from
Department of Pathology, Saiseikai Shiga Hospital, for her pathological
comments on the pathology of this case.
REFERENCES
1 Wanless IR, Mawdsley C, Adams R. On the pathogenesis of hepatic focal
nodular hyperplasia. Hepatology 1985;5:1194–1200.
2 Brancatelli G, Federle MP, Grazioli L, Blachar A, Peterson MS, Thaete L.
Focal nodular hyperplasia: CT findings with emphasis on multiphasic
helical CT in 78 patients. Radiology 2001;219:61–68.
3 Mortele KJ, Praet M, Van Vlierberghe H, Kunnen M, Ros PR. CT and MR
imaging findings in focal nodular hyperplasia of the liver: Radiologic-
pathologic correlation. AJR Am J Roentgenol 2000;175:687–692.
4 Uggowitzer M, Kugler C, Groll R, et al. Sonographic evaluation of focal
nodular hyperplasia (FNH) of the liver with a transpulmonary galactose-
based contrast agent (Levovist). Br J Radiol 1998;71:1026–1032.
5 Quiroga S, Sebastia C, Pallisa E, Castella E, Perez-Lafuente M, Alvarez-
Castells A. Improved diagnosis of hepatic perfusion disorders: value of
hepatic arterial phase imaging during helical CT. RadioGraphics 2001;
21:65–81.
6 Itai Y, Murata S, Kurosaki Y. Straight border sign of the liver: spectrum
of CT appearances and causes. RadioGraphics 1995;15:1089–1102.
7 Arita T, Matsunaga N, Honma Y, Nishikawa E, Nagaoka S. Focally
spared area of fatty liver caused by arteiroportal shunt. J Comput Assist
Tomogr 1996;20:360–362.
8 Hytiroglou P, Theise ND. Differential diagnosis of hepatocellular
nodular lesions. Semin Diagn Pathol 1998;14:285–299.
CASE REPORT 9
